Literature DB >> 21062777

Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study.

Karen Sliwa1, Melinda Jane Carrington, Eric Klug, Lionel Opie, Geraldine Lee, Jocasta Ball, Simon Stewart.   

Abstract

BACKGROUND: Little is known about the incidence and clinical characteristics of newly diagnosed atrial fibrillation/flutter (AF) in urban Africans in epidemiological transition.
METHODS: This observational cohort study was carried out in the Chris Hani Baragwanath Hospital in Soweto South Africa. A clinical registry captured detailed clinical data on all de novo cases of AF presenting to the Cardiology Unit during the period 2006-2008.
RESULTS: Overall, 246 of 5328 cardiac cases (4.6%) presented with AF (estimated 5.6 cases/100 000 population/annum). Mean age was 59±18 years and the majority were of African descent (n=211, 86%) and/or female (n=150, 61%). Men were more than twice as likely to smoke (OR 2.88, 95% CI 1.92 to 4.04) than women, but women were twice as likely to be obese (OR 1.80, 95% CI 1.28 to 2.52) than men. Lone AF occurred in 22 (8.9%) cases, while concurrent valve disease and/or functional valvular abnormality occurred in 107 cases (44%). Overall, 171 cases (70%) presented with uncontrolled AF (ventricular rate >90 beats/min) with no sex-based differences. Common co-morbidities were any form of heart failure (56%) and rheumatic heart disease (21%). Women with AF were more likely to present with hypertensive heart failure (OR 2.37, 95% CI 1.24 to 4.54) but less likely to present with a dilated cardiomyopathy (OR 0.42, 95% CI 0.23 to 0.76) or coronary artery disease (OR 0.38, 95% CI 0.14 to 1.02) than men. Mean overall CHADS(2) score (in 195 non-rheumatic cases) was 1.51±0.91 and, despite a similar age profile, women had higher scores than men (1.73±0.94 vs 1.24±0.78; p<0.0001).
CONCLUSIONS: These unique data suggest that urban Africans in Soweto develop AF at a relatively young age. Conventional strategies used to manage and treat AF need to be carefully evaluated in this setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062777     DOI: 10.1136/hrt.2010.206938

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  24 in total

1.  Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study.

Authors:  Rahul G Muthalaly; Bruce A Koplan; Alfred Albano; Crystal North; Jeffrey I Campbell; Bernard Kakuhikire; Dagmar Vořechovská; John D Kraemer; Alexander C Tsai; Mark J Siedner
Journal:  Int J Cardiol       Date:  2018-05-24       Impact factor: 4.164

2.  Growing importance of valvular heart disease in the elderly.

Authors:  Yan Chen; Kai-Hang Yiu
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 3.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

4.  Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort.

Authors:  Karen Sliwa; Melinda J Carrington; Anthony Becker; Friedrich Thienemann; Mpiko Ntsekhe; Simon Stewart
Journal:  Eur Heart J       Date:  2011-11-01       Impact factor: 29.983

Review 5.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

Review 6.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

7.  Atrial Fibrillation and Race - A Contemporary Review.

Authors:  Michael K D Amponsah; Emelia J Benjamin; Jared W Magnani
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10

Review 8.  The Optimal Treatment For Atrial Fibrillation In Less Developed Countries.

Authors:  Xiaohan Fan; Shu Zhang
Journal:  J Atr Fibrillation       Date:  2014-10-31

Review 9.  Protective cardiovascular and renal actions of vitamin D and estrogen.

Authors:  Pandu R Gangula; Yuan-Lin Dong; Ayman Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Georges Haddad; Rihcard Millis; Susanne B Nicholas; Diane Moseberry
Journal:  Front Biosci (Schol Ed)       Date:  2013-01-01

10.  Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY).

Authors:  Jocasta Ball; Melinda J Carrington; Kathryn A Wood; Simon Stewart
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.